Multicenter, Double-Blind, Randomized, Placebo-ControlledStudy to Evaluate Safety, Tolerability, and Efficacy ofIxekizumab in Patients from 6 to Less than 18 Years of Age with Moderate-to-Severe Plaque Psoriasis

Project: Research project

Project Details

StatusFinished
Effective start/end date5/1/179/27/20

Funding

  • Northwestern University
  • Eli Lilly and Company